Quick Takeaways
- This page summarizes Brian O'Callaghan's Form 4 filing for Bolt Biotherapeutics, Inc. (BOLT).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 14 Jun 2023, 17:19.
Brian O'Callaghan - 12 Jun 2023 Form 4 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)
- Role
- Director
- Signature
- /s/ William P. Quinn, Attorney-in-Fact
- Issuer symbol
- BOLT
- Transactions as of
- 12 Jun 2023
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 14 Jun 2023, 17:19:49 UTC
- Previous filing
- 03 Jan 2023
- Next filing
- 14 Jun 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Brian O'Callaghan filed Form 4 for Bolt Biotherapeutics, Inc. (BOLT) on 14 Jun 2023."
What Changed
- Previous filing in this sequence was filed on 03 Jan 2023.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BOLT | Stock Option (Right to Buy) | Award | $0 | +25,000 | $0.000000 | 25,000 | 12 Jun 2023 | Common Stock | 25,000 | $1.63 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The shares subject to the option will vest on the earlier of June 12, 2024 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer. |